1. Home
  2. TWLO vs IQV Comparison

TWLO vs IQV Comparison

Compare TWLO & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twilio Inc.

TWLO

Twilio Inc.

HOLD

Current Price

$231.31

Market Cap

31.8B

Sector

Technology

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$241.80

Market Cap

35.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWLO
IQV
Founded
2008
1982
Country
United States
United States
Employees
N/A
93000
Industry
Computer Software: Prepackaged Software
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.8B
35.1B
IPO Year
2016
2013

Fundamental Metrics

Financial Performance
Metric
TWLO
IQV
Price
$231.31
$241.80
Analyst Decision
Buy
Strong Buy
Analyst Count
24
16
Target Price
$151.54
$227.13
AVG Volume (30 Days)
2.4M
1.4M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
131.82
4.67
EPS
7.29
1.61
Revenue
$399,020,000.00
$9,739,000,000.00
Revenue This Year
$14.44
$6.77
Revenue Next Year
$8.21
$5.89
P/E Ratio
$32.67
$146.99
Revenue Growth
43.88
41.60
52 Week Low
$98.44
$154.50
52 Week High
$258.35
$251.36

Technical Indicators

Market Signals
Indicator
TWLO
IQV
Relative Strength Index (RSI) 59.70 61.36
Support Level $114.75 $222.95
Resistance Level $233.85 $247.52
Average True Range (ATR) 11.81 7.41
MACD 4.03 -0.85
Stochastic Oscillator 67.28 45.02

Price Performance

Historical Comparison
TWLO
IQV

About TWLO Twilio Inc.

Twilio is a cloud-based communications platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: